Aprea Therapeutics, Inc.
APRE
$0.79
$0.000.01%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.95M | -12.60M | -13.04M | -13.85M | -14.08M |
| Total Depreciation and Amortization | 21.60K | 21.60K | 21.60K | 21.60K | 21.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 535.50K | 612.50K | 542.50K | 607.70K | 575.80K |
| Change in Net Operating Assets | -622.40K | -929.20K | -969.70K | 479.50K | 231.80K |
| Cash from Operations | -12.02M | -12.89M | -13.44M | -12.74M | -13.25M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -7.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | -7.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 40.09M | 5.05M | 975.20K | 599.80K | 200.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -878.70K | -407.40K | -42.10K | -25.90K | -32.10K |
| Cash from Financing | 39.21M | 4.64M | 933.00K | 573.90K | 167.90K |
| Foreign Exchange rate Adjustments | 3.00K | 4.70K | -21.20K | 4.10K | -3.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.19M | -8.25M | -12.53M | -12.16M | -13.09M |